Plain-language guidance for clinic owners and providers navigating compounding pharmacy relationships. No legalese. No ambiguity. Just clear answers to the questions you're actually asking.
What's the difference between a 503A patient-specific pharmacy and a 503B FDA-registered outsourcing facility? When does your clinic need each? Clear answers with licensing requirements explained.
Semaglutide was removed from the FDA shortage list. What does that mean for your clinic? What's still legal to compound, what isn't, and what the compliant pathways look like now.
A step-by-step pre-partnership checklist: state licensing, NABP/PCAB accreditation, BAA execution, BUD dating, cGMP compliance, and liability coverage — everything you need to verify.
Why every clinic needs a BAA with their compounding pharmacy partner, what it must cover, and how Veridian facilitates this requirement automatically in the onboarding process.
For clinics found to have distributed compounded medications through non-compliant pharmacy relationships.
Each state board has its own licensing and dispensing rules layered on top of federal FDA requirements. Navigating this is genuinely complex.
Every pharmacy in our network is pre-verified for state licensing, accreditation status, cGMP compliance, and BAA readiness before clinics can access them.
You shouldn't need a law degree to source compounded medications safely. Our network only includes pharmacies that meet our rigorous compliance standards — so you can focus on patient care.
Apply for Access →Weekly From Veridian
One email a week. Useful every time. Unsubscribe whenever.
Join clinic operators staying current on compounding compliance and GLP-1 sourcing.